SCHEMBL8076004

SCHEMBL8076004

CCCCc1nc(C(Cl)c2ccc(-c3ccccc3)c(C(=O)O)c2)c(CO)[nH]1

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BRS3 P32247 9/20 0.46
AGTR1 P30556 3/20 0.38
AGTR2 P50052 3/20 0.38
DHODH Q02127 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6534773 0.89 BRS3 (0.54) BRS3AGTR1AGTR2
SCHEMBL8070880 0.84 XDH (0.36) BRS3AGTR1AGTR2
SCHEMBL8741233 0.81 GCGR (0.32) BRS3
SCHEMBL6534662 0.78 BRS3 (0.48) BRS3AGTR1AGTR2
SCHEMBL3460737 0.77 PPARG (0.40) BRS3AGTR1AGTR2
SCHEMBL6534730 0.76 BRS3 (0.52) BRS3AGTR1AGTR2
SCHEMBL6534844 0.76 BRS3 (0.46) BRS3AGTR1AGTR2
SCHEMBL7050688 0.74 AGTR1 (0.34) BRS3AGTR1AGTR2
SCHEMBL7322921 0.73 BRS3 (0.49) BRS3
SCHEMBL7315650 0.72 BRS3 (0.48) BRS3AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1019048-A1 USE OF AN ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREPARATION OF DRUGS TO INCREASE THE SURVIVAL RATE OF RENAL TRANSPLANT PATIENTS Merck Sharp Dohme (Italia) S.P.A. (IT) 2000-07-19 EP claimed
WO-1999016437-A1 USE OF AN ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREPARATION OF DRUGS TO INCREASE THE SURVIVAL RATE OF RENAL TRANSPLANT PATIENTS MERCK SHARP DOHME (ITALIA) S.P.A. (IT) 1999-04-08 WO claimed